{
    "nctId": "NCT00183885",
    "title": "A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Unresectable, histologically confirmed hepatocellular carcinoma with evident disease limited to liver."
                    },
                    {
                        "type": "variable",
                        "value": "Tissue from tumor must be available."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must agree to have a 20 cc blood sample drawn in addition to routine labs with each cycle of chemotherapy."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have measurable disease."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have a Zubrod performance status of 0-2."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have a predicted life expectancy of at least 12 weeks."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have a pre-treatment granulocyte count (i.e., segmented neutrophils + bands) of greater than or equal to 1,500/mm3."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have a hemoglobin level of greater than or equal to 9 gm/dl."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have a platelet count greater than or equal to 50,000/mm3."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have adequate renal function as documented by a calculated creatinine clearance \u2265 60."
                    },
                    {
                        "type": "variable",
                        "value": "Patients must have adequate hepatic function as documented by a serum bilirubin less than or equal to 2x the institutional upper limit of normal."
                    },
                    {
                        "type": "variable",
                        "value": "Patients may not have ascites or the ascites must be responsive to diuretics."
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients who have received prior chemotherapy for unresectable disease"
                            },
                            {
                                "type": "variable",
                                "value": "Patients with any active or uncontrolled infection, including known HIV infection."
                            },
                            {
                                "type": "variable",
                                "value": "Patients with psychiatric disorders that would interfere with consent or follow-up."
                            },
                            {
                                "type": "variable",
                                "value": "Pregnant or lactating women."
                            },
                            {
                                "type": "variable",
                                "value": "Men and women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method."
                            },
                            {
                                "type": "variable",
                                "value": "Patients with any other severe concurrent disease, which in the judgment of the investigator, would make the patient inappropriate for entry into this study."
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Must have minimum age of 18 Years'), Symbol('Patients may not have ascites or the ascites must be responsive to diuretics.'), Symbol('Patients must agree to have a 20 cc blood sample drawn in addition to routine labs with each cycle of chemotherapy.'), Symbol('Patients must have a Zubrod performance status of 0-2.'), Symbol('Patients must have a hemoglobin level of greater than or equal to 9 gm/dl.'), Symbol('Patients must have a platelet count greater than or equal to 50,000/mm3.'), Symbol('Patients must have a pre-treatment granulocyte count (i.e., segmented neutrophils + bands) of greater than or equal to 1,500/mm3.'), Symbol('Patients must have a predicted life expectancy of at least 12 weeks.'), Symbol('Patients must have adequate hepatic function as documented by a serum bilirubin less than or equal to 2x the institutional upper limit of normal.'), Symbol('Patients must have adequate renal function as documented by a calculated creatinine clearance \u2265 60.'), Symbol('Patients must have measurable disease.'), Symbol('Tissue from tumor must be available.'), Symbol('Unresectable, histologically confirmed hepatocellular carcinoma with evident disease limited to liver.'), Not(Or(Symbol('Men and women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method.'), Symbol('Patients who have received prior chemotherapy for unresectable disease'), Symbol('Patients with any active or uncontrolled infection, including known HIV infection.'), Symbol('Patients with any other severe concurrent disease, which in the judgment of the investigator, would make the patient inappropriate for entry into this study.'), Symbol('Patients with psychiatric disorders that would interfere with consent or follow-up.'), Symbol('Pregnant or lactating women.'))))"
}